Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of “Moderate Buy” from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $35.10.

Several analysts have recently commented on OPCH shares. JMP Securities raised their target price on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a research note on Thursday, July 31st. TD Cowen started coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating and a $30.00 target price for the company. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Wednesday, October 8th. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research restated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Tuesday, September 23rd.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $27.91 on Monday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The business has a 50-day moving average price of $27.99 and a two-hundred day moving average price of $30.11. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a market cap of $4.53 billion, a P/E ratio of 22.33, a PEG ratio of 1.70 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period last year, the business posted $0.30 EPS. The business’s revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts anticipate that Option Care Health will post 1.22 EPS for the current year.

Insider Activity

In other news, Director Timothy P. Sullivan bought 20,000 shares of Option Care Health stock in a transaction dated Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the purchase, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This represents a 68.43% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the business’s stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock worth $1,627,576 in the last three months. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently modified their holdings of OPCH. Farther Finance Advisors LLC raised its holdings in shares of Option Care Health by 434.8% in the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock worth $67,000 after purchasing an additional 1,561 shares during the period. GAMMA Investing LLC raised its holdings in shares of Option Care Health by 307.1% in the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock worth $112,000 after purchasing an additional 2,408 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Option Care Health by 25.7% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock worth $289,000 after purchasing an additional 1,691 shares during the period. State of Alaska Department of Revenue raised its holdings in shares of Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company’s stock worth $696,000 after purchasing an additional 525 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Option Care Health by 95.4% in the 1st quarter. Blue Trust Inc. now owns 5,282 shares of the company’s stock worth $185,000 after purchasing an additional 2,579 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.